Botulinum neurotoxin type B uses a distinct entry pathway mediated by CDC42 into intestinal cells versus neuronal cells

Cellular Microbiology

Volumn 19, Issue 8, 2017, Pages

  Connan, Chloé ^a   Voillequin, Marie ^a   Chavez, Carolina Varela ^a   Mazuet, Christelle ^a   Leveque, Christian ^b   Vitry, Sandrine ^a   Vandewalle, Alain ^c   Popoff, Michel R ^a  

^a INSTITUT PASTEUR   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

botulinum neurotoxin; Cdc42; endocytosis; gangliosides; intestinal cells; neuronal cells

Indexed keywords

BOTULINUM TOXIN B; DYNAMIN; DYNASORE; EARLY ENDOSOME ANTIGEN 1; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; PROTEIN CDC42; SYNAPTOTAGMIN I; SYNAPTOTAGMIN II; BOTULINUM TOXIN A; CDC42 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CONTROLLED STUDY; EMBRYO; ENDOCYTOSIS; FETUS; HEAVY CHAIN; INTESTINE CELL; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; TRANSCYTOSIS; ANIMAL; EPITHELIUM CELL; METABOLISM;

ANIMALS; BOTULINUM TOXINS, TYPE A; CDC42 GTP-BINDING PROTEIN; ENDOCYTOSIS; EPITHELIAL CELLS; MICE; NEURONS;

EID: 85017594861     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12738     Document Type: Article

References (102)

1. Ahsan, C. R., Hajnoczky, G., Maksymowych, A. B., & Simpson, L. L. (2005). Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells. The Journal of Pharmacology and Experimental Therapeutics, 315, 1028–1035.
2. Arnon, S. S. (1989). Infant botulism. In S. M. Finegold, & W. L. George (Eds.), Anaerobic infections in humans (pp. 601–609). San Diego, CA: Academic Press.
3. Barash, J. R., & Arnon, S. S. (2014). A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. The Journal of Infectious Diseases. 209, 183–191. https://doi.org/10.1093/infdis/jit449. Epub 2013 Oct 1097.
4. Beard, M. (2014). Translocation, entry into the cell. In K. A. Foster (Ed.), Molecular aspects of botulinum neurotoxins (pp. 151–170). Abingdon: Springer.
5. Bens, M., Bogdanova, A., Cluzeaud, F., Miquerol, L., Kerneis, S., Kraehenbuhl, J. P., … Vandewalle, A. (1996). Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype. The American Journal of Physiology, 270, C1666–C1674.
6. Bohnert, S., & Schiavo, G. (2005). Tetanus toxin is transported in a novel neuronal compartment characterized by a specialized pH regulation. The Journal of Biological Chemistry, 280, 42336–42344.
7. Brashear, A., Lew, M. F., Dykstra, D. D., Comella, C. L., Factor, S. A., Rodnitzky, R. L., … Koller, M. (1999). Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology, 53, 1439–1446.
8. Brook, I. (2007). Infant botulism. Journal of Perinatology, 27, 175–180.
9. Carpentier, J. L., Sawano, F., Geiger, D., Gorden, P., Perrelet, A., & Orci, L. (1989). Potassium depletion and hypertonic medium reduce "non-coated" and clathrin-coated pit formation as well as endocytosis through these two gates. Journal of Cellular Physiology, 138, 519–526.
10. Chadda, R., Howes, M. T., Plowman, S. J., Hancock, J. F., Parton, R. G., & Mayor, S. (2007). Cholesterol-sensitive Cdc42 activation regulates actin polymerization for endocytosis via the GEEC pathway. Traffic, 8, 702–717.
11. Chai, Q., Arndt, J. W., Dong, M., Tepp, W. H., Johnson, E. A., Chapman, E. R., & Stevens, R. C. (2006). Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature, 444, 1096–1100.
12. Charvin, N., L'Eveque, C., Walker, D., Berton, F., Raymond, C., Kataoka, M., … Seagar, M. J. (1997). Direct interaction of the calcium sensor protein synaptotagmin I with a cytoplasmic domain of the alpha1A subunit of the P/Q-type calcium channel. The EMBO Journal, 16, 4591–4596.
13. Chen, F., Vitry, S., Hocquemiller, M., Desmaris, N., Ausseil, J., & Heard, J. M. (2006). alpha-L-Iduronidase transport in neurites. Molecular Genetics and Metabolism, 87, 349–358.
14. Chen, H., Gao, Z., He, C., Xiang, R., van Kuppevelt, T. H., Belting, M., & Zhang, S. (2016). GRP75 upregulates clathrin-independent endocytosis through actin cytoskeleton reorganization mediated by the concurrent activation of Cdc42 and RhoA. Experimental Cell Research, 343, 223–236.
15. Cheng, Z. J., Singh, R. D., Holicky, E. L., Wheatley, C. L., Marks, D. L., & Pagano, R. E. (2010). Co-regulation of caveolar and Cdc42-dependent fluid phase endocytosis by phosphocaveolin-1. The Journal of Biological Chemistry, 285, 15119–15125.
16. Cherington, M. (1998). Clinical spectrum of botulism. Muscle & Nerve, 21, 701–710.
17. Chi, X., Wang, S., Huang, Y., Stamnes, M., & Chen, J. L. (2013). Roles of rho GTPases in intracellular transport and cellular transformation. International Journal of Molecular Sciences, 14, 7089–7108.
18. Christoforidis, S., McBride, H. M., Burgoyne, R. D., & Zerial, M. (1999). The Rab5 effector EEA1 is a core component of endosome docking. Nature, 397, 621–625.
19. Connan, C., Varela-Chavez, C., Mazuet, C., Molgo, J., Haustant, G. M., Disson, O., … Popoff, M. R. (2016). Translocation and dissemination to target neurons of botulinum neurotoxin type B in the mouse intestinal wall. Cellular Microbiology, 18, 282–301.
20. Couesnon, A., Colasante, C., Molgo, J., & Popoff, M. R. (2010). Differential entry of botulinum neurotoxin A into neuronal and intestinal cells: An ultrastructural approach. Botulinum J., 1, 375–392.
21. Couesnon, A., Molgo, J., Connan, C., & Popoff, M. R. (2012). Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine. PLoS Pathogens, 8, e1002583.
22. Couesnon, A., Pereira, Y., & Popoff, M. R. (2008). Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers. Cellular Microbiology, 10, 375–387.
23. Couesnon, A., Shimizu, T., & Popoff, M. R. (2009). Differential entry of botulinum neurotoxin A into neuronal and intestinal cells. Cellular Microbiology, 11, 289–308.
24. Dong, M., Richards, D. A., Goodnough, M. C., Tepp, W. H., Johnson, E. A., & Chapman, E. R. (2003). Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. The Journal of Cell Biology, 162, 1293–1303.
25. Elias, M., Al-Saleem, F., Ancharski, D. M., Singh, A., Nasser, Z., Olson, R. M., & Simpson, L. L. (2011). Evidence that botulinum toxin receptors on epithelial cells and neuronal cells are not identical: Implications for development of a non-neurotropic vaccine. The Journal of Pharmacology and Experimental Therapeutics, 336, 605–612.
26. Etienne-Manneville, S., & Hall, A. (2002). Rho GTPases in cell biology. Nature, 420, 629–635.
27. Ewers, H., Romer, W., Smith, A. E., Bacia, K., Dmitrieff, S., Chai, W., … Johannes, L. (2010). GM1 structure determines SV40-induced membrane invagination and infection. Nature Cell Biology, 12, 11–18; sup pp 11-12.
28. Feng, Y., Press, B., & Wandinger-Ness, A. (1995). Rab 7: An important regulator of late endocytic membrane traffic. The Journal of Cell Biology, 131, 1435–1452.
29. Fenicia, L., & Anniballi, F. (2009). Infant botulism. Annali dell'Istituto Superiore di Sanità, 45, 134–146.
30. Fox, C. K., Keet, C. A., & Strober, J. B. (2005). Recent advances in infant botulism. Pediatric Neurology, 32, 149–154.
31. Fujinaga, Y., Inoue, K., Watanabe, S., Yokota, K., Hirai, Y., Nagamachi, E., & Oguma, K. (1997). The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig intestine, leading to the efficient absorption of the toxin. Microbiology, 143, 3841–3847.
32. Gauthier, N. C., Monzo, P., Kaddai, V., Doye, A., Ricci, V., & Boquet, P. (2005). Helicobacter pylro VacA cytotoxin: A probe for a clathrin-independent and Cdc42-dependent pinocytic pathway routed to late endosomes. Molecular Biology of the Cell, 16, 4852–4866.
33. Girard, E., Chmiest, D., Fournier, N., Johannes, L., Paul, J. L., Vedie, B., & Lamaze, C. (2014). Rab7 is functionally required for selective cargo sorting at the early endosome. Traffic, 15, 309–326.
34. Grant, B. D., & Donaldson, J. G. (2009). Pathways and mechanisms of endocytic recycling. Nature Reviews. Molecular Cell Biology, 10, 597–608.
35. Gu, S., Rumpel, S., Zhou, J., Strotmeier, J., Bigalke, H., Perry, K., … Jin, R. (2012). Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science, 335, 977–981.
36. Hall, A. (2012). Rho family GTPases. Biochemical Society Transactions, 40, 1378–1382. https://doi.org/10.1042/BST20120103
37. Harper, C. B., Martin, S., Nguyen, T. H., Daniels, S. J., Lavidis, N. A., Popoff, M. R., … Meunier, F. A. (2011). Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism. The Journal of Biological Chemistry, 286, 35966–35976.
38. Harris, K. P., & Tepass, U. (2010). Cdc42 and vesicle trafficking in polarized cells. Traffic, 11, 1272–1279.
39. Hill, K. K., & Smith, T. J. (2013). Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Current Topics in Microbiology and Immunology, 364, 1–20.
40. Howes, M. T., Mayor, S., & Parton, R. G. (2010). Molecules, mechanisms, and cellular roles of clathrin-independent endocytosis. Current Opinion in Cell Biology, 22, 519–527.
41. Hughes, J. M., Blumenthal, J. R., Merson, M. H., Lombard, G. L., Dowell, V. R. Jr., & Gangarosa, E. J. (1981). Clinical features of types A and B food-borne botulism. Annals of Internal Medicine, 95, 442–445.
42. Inui, K., Sagane, Y., Miyata, K., Miyashita, S., Suzuki, T., Shikamori, Y., … Watanabe, T. (2012). Toxic and nontoxic components of botulinum neurotoxin complex are evolved from a common ancestral zinc protein. Biochemical and Biophysical Research Communications, 419, 500–504.
43. Jin, R., Rummel, A., Binz, T., & Brunger, A. T. (2006). Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature, 444, 1092–1095.
44. Jin, Y., Takegahara, Y., Sugawara, Y., Matsumura, T., & Fujinaga, Y. (2009). Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins—Differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. Microbiology, 155, 35–45.
45. Kalia, M., Kumari, S., Chadda, R., Hill, M. M., Parton, R. G., & Mayor, S. (2006). Arf6-independent GPI-anchored protein-enriched early endosomal compartments fuse with sorting endosomes via a Rab5/phosphatidylinositol-3'-kinase-dependent machinery. Molecular Biology of the Cell, 17, 3689–3704.
46. Keller, J. E., Cai, F., & Neale, E. A. (2004). Uptake of botulinum neurotoxin into cultured neurons. The Biochemist, 43, 526–532.
47. Kovbasnjuk, O., Edidin, M., & Donowitz, M. (2001). Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. Journal of Cell Science, 114, 4025–4031.
48. Lakshminarayan, R., Wunder, C., Becken, U., Howes, M. T., Benzing, C., Arumugam, S., … Johannes, L. (2014). Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers. Nature Cell Biology, 16, 595–606.
49. Lalli, G., Gschmeissner, S., & Schiavo, G. (2003). Myosin Va and microtubule-based motors are required for fast axonal retrograde transport of tetanus toxin in motor neurons. Journal of Cell Science, 116, 4639–4650.
50. Lam, T. I., Stanker, L. H., Lee, K., Jin, R., & Cheng, L. W. (2015). Translocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epithelia. Cellular Microbiology, 17, 1133–1143.
51. Lee, K., Zhong, X., Gu, S., Kruel, A. M., Dorner, M. B., Perry, K., … Jin, R. (2014). Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex. Science, 344, 1405–1410. https://doi.org/10.1126/science.1253823
52. Macia, E., Ehrlich, M., Massol, R., Boucrot, E., Brunner, C., & Kirchhausen, T. (2006). Dynasore, a cell-permeable inhibitor of dynamin. Developmental Cell, 10, 839–850.
53. Maksymowych, A. B., & Simpson, L. I. (2004). Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells. The Journal of Pharmacology and Experimental Therapeutics, 310, 633–641.
54. Maksymowych, A. B., & Simpson, L. L. (1998). Binding and transcytosis of botulinum neurotoxin by polarized human carcinoma cells. The Journal of Biological Chemistry, 273, 21950–21957.
55. Maldonado-Baez, L., Williamson, C., & Donaldson, J. G. (2013). Clathrin-independent endocytosis: A cargo-centric view. Experimental Cell Research, 319, 2759–2769.
56. Malyukova, I., Murray, K. F., Zhu, C., Boedeker, E., Kane, A., Patterson, K., … Kovbasnjuk, O. (2009). Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis. American Journal of Physiology. Gastrointestinal and Liver Physiology, 296, G78–G92.
57. Maslanka, S. E., Luquez, C., Dykes, J. K., Tepp, W. H., Pier, C. L., Pellett, S., … Johnson, E. A. (2016). A novel botulinum neurotoxin, previously reported as serotype H, has a hybrid-like structure with regions of similarity to the structures of serotypes A and F and is neutralized with serotype A antitoxin. The Journal of Infectious Diseases, 213, 379–385.
58. Mayor, S., & Pagano, R. E. (2007). Pathways of clathrin-independent endocytosis. Nature Reviews. Molecular Cell Biology, 8, 603–612.
59. Meng, J., Wang, J., Lawrence, G. W., & Dolly, J. O. (2013). Molecular components required for resting and stimulated endocytosis of botulinum neurotoxins by glutamatergic and peptidergic neurons. The FASEB Journal, 27, 3167–3180. https://doi.org/10.1096/fj.13-228973 Epub 222013 May 228972.
60. Merz, B., Bigalke, H., Stoll, G., & Naumann, M. (2003). Botulism type B presenting as pure autonomic dysfunction. Clinical Autonomic Research, 13, 337–338.
61. Musch, M. W., Arvans, D. L., Wang, Y., Nakagawa, Y., Solomaha, E., & Chang, E. B. (2010). Cyclic AMP-mediated endocytosis of intestinal epithelial NHE3 requires binding to synaptotagmin 1. American Journal of Physiology. Gastrointestinal and Liver Physiology, 298, G203–G211.
62. Nishikawa, A., Uotsu, N., Arimitsu, H., Lee, J. C., Miura, Y., Fujinaga, Y., … Oguma, K. (2004). The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells. Biochemical and Biophysical Research Communications, 319, 327–333.
63. Nishiki, T., Kamata, Y., Nemoto, Y., Omori, A., Ito, T., Takahashi, M., & Kozaki, S. (1994). Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. The Journal of Biological Chemistry, 269, 10498–10503.
64. D1a. FEBS Letters, 378, 253–257.
65. Nishiki, T., Tokuyama, Y., Kamata, Y., Nemoto, Y., Yoshida, A., Sekiguchi, M., … Kozaki, S. (1996). Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA. Neuroscience Letters, 208, 105–108.
66. Oguma, K., Inoue, K., Fujinaga, Y., Yokota, K., Watanabe, T., Ohyama, T., … Inoue, K. (1999). Structure and function of Clostridium botulinum progenitor toxin. Journal of Toxicology, 18, 17–34.
67. Park, J. B., & Simpson, L. L. (2003). Inhalation poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component. Infection and Immunity, 71, 1147–1154.
68. Peck, M. W., Smith, T. J., Anniballi, F., Austin, J. W., Bano, L., Bradshaw, M., … Stringer, S. C. (2017). Historical perspectives and guidelines for botulinum neurotoxin subtype nomenclature. Toxins (Basel), 9.
69. Pezeshkian, W., Hansen, A. G., Johannes, L., Khandelia, H., Shillcock, J. C., Kumar, P. B., & Ipsen, J. H. (2016). Membrane invagination induced by Shiga toxin B-subunit: From molecular structure to tube formation. Soft Matter, 12, 5164–5171.
70. Popoff, M. R., & Marvaud, J. C. (1999). Structural and genomic features of clostridial neurotoxins. In J. E. Alouf, & J. H. Freer (Eds.), The comprehensive sourcebook of bacterial protein toxins (2nd ed.) (pp. 174–201). London: Academic Press.
71. Popoff, M. R., Mazuet, C., & Poulain, B. (2013). Botulism and tetanus. In The prokaryotes: Human microbiology (4th ed.) (pp. 247–290). Berlin Heidelberg: Springer-Verlag.
72. Poteryaev, D., Datta, S., Ackema, K., Zerial, M., & Spang, A. (2010). Identification of the switch in early-to-late endosome transition. Cell, 141, 497–508.
73. Potulska-Chromik, A., Zakrzewska-Pniewska, B., Szmidt-Salkowska, E., Lewandowski, J., Sinski, M., Przyjalkowski, W., & Kostera-Pruszczyk, A. (2013). Long lasting dysautonomia due to botulinum toxin B poisoning: Clinical-laboratory follow up and difficulties in initial diagnosis. BMC Research Notes, 6, 438. https://doi.org/10.1186/1756-0500-1186-1438
74. Poulain, B., Popoff, M. R., & Molgo, J. (2008). How do the botulinum neurotoxins block neurotransmitter release: From botulism to the molecular mechanism of action. Botulinum Journal, 1, 14–87.
75. Preta, G., Cronin, J. G., & Sheldon, I. M. (2015). Dynasore—Not just a dynamin inhibitor. Cell Communication and Signaling: CCS, 13, 24.
76. Quinn, C. P., & Minton, N. P. (2001). Clostridial neurotoxins. In H. Bahl, & P. Dürre (Eds.), Clostridia (pp. 211–250). Willey-VCH: Veinheim.
77. Restani, L., Giribaldi, F., Manich, M., Bercsenyi, K., Menendez, G., Rossetto, O., … Schiavo, G. (2012). Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons. PLoS Pathogens, 8, e1003087.
78. Rink, J., Ghigo, E., Kalaidzidis, Y., & Zerial, M. (2005). Rab conversion as a mechanism of progression from early to late endosomes. Cell, 122, 735–749.
79. Rojas, R., Ruiz, W. G., Leung, S. M., Jou, T. S., & Apodaca, G. (2001). Cdc42-dependent modulation of tight junctions and membrane protein traffic in polarized Madin-Darby canine kidney cells. Molecular Biology of the Cell, 12, 2257–2274.
80. Romer, W., Berland, L., Chambon, V., Gaus, K., Windschiegl, B., Tenza, D., … Johannes, L. (2007). Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature, 450, 670–675.
81. Rosow, L. K., & Strober, J. B. (2015). Infant botulism: Review and clinical update. Pediatric Neurology, 52, 487–492.
82. Rossetto, O., Pirazzini, M., & Montecucco, C. (2014). Botulinum neurotoxins: Genetic, structural and mechanistic insights. Nature Reviews. Microbiology, 12, 535–549. https://doi.org/10.1038/nrmicro3295 Epub 2014 Jun 1030.
83. Roux, S., Saint Cloment, C., Curie, T., Girard, E., Mena, F. J., Barbier, J., … Brulet, P. (2006). Brain-derived neurotrophic factor facilitates in vivo internalization of tetanus neurotoxin C-terminal fragment fusion proteins in mature mouse motor nerve terminals. The European Journal of Neuroscience, 24, 1546–1554.
84. Rummel, A. (2013). Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Current Topics in Microbiology and Immunology, 364, 61–90. https://doi.org/10.1007/1978-1003-1642-33570-33579_33574
85. Rummel, A., Eichner, T., Weil, T., Karnath, T., Gutcaits, A., Mahrhold, S., … Binz, T. (2007). Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proceedings of the National Academy of Sciences of the United States of America, 104, 359–364.
86. Sabharanjak, S., Sharma, P., Parton, R. G., & Mayor, S. (2002). GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Developmental Cell, 2, 411–423.
87. Sagane, Y., Miyashita, S., Miyata, K., Matsumoto, T., Inui, K., Hayashi, S., … Watanabe, T. (2012). Small-angle X-ray scattering reveals structural dynamics of the botulinum neurotoxin associating protein, nontoxic nonhemagglutinin. Biochemical and Biophysical Research Communications, 425, 256–260.
88. Sharma, S. K., Ramzan, M. A., & Singh, B. R. (2003). Separation of the components of type A botulinum neeurotoxin complex by electrophoresis. Toxicon, 41, 321–331.
89. Shin, H. W., Hayashi, M., Christoforidis, S., Lacas-Gervais, S., Hoepfner, S., Wenk, M. R., … Zerial, M. (2005). An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. The Journal of Cell Biology, 170, 607–618.
90. Simonsen, A., Lippe, R., Christoforidis, S., Gaullier, J. M., Brech, A., Callaghan, J., … Stenmark, H. (1998). EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature, 394, 494–498.
91. Simpson, L. L., Coffield, J. A., & Bakry, N. (1994). Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins. The Journal of Pharmacology and Experimental Therapeutics, 269, 256–262.
92. Sobel, J. (2005). Botulism. Clinical Infectious Diseases, 41, 1167–1173.
93. Sudhof, T. C. (2013). Neurotransmitter release: The last millisecond in the life of a synaptic vesicle. Neuron, 80, 675–690.
94. Sugawara, Y., & Fujinaga, Y. (2011). The botulinum toxin complex meets E-cadherin on the way to its destination. Cell Adhesion & Migration, 5, 34–36.
95. Sugawara, Y., Matsumura, T., Takegahara, Y., Jin, Y., Tsukasaki, Y., Takeichi, M., & Fujinaga, Y. (2010). Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin. The Journal of Cell Biology, 189, 691–700.
96. Tapon, N., & Hall, A. (1997). Rho, Rac and CDC42 GTPases regulate the organization of the actin cytoskeleton. Current Biology, 9, 86–92.
97. Tavallaie, M., Chenal, A., Gillet, D., Pereira, Y., Manich, M., Gibert, M., … Marvaud, J. C. (2004). Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies. FEBS Letters, 572, 299–306.
98. Wandinger-Ness, A., & Zerial, M. (2014). Rab proteins and the compartmentalization of the endosomal system. Cold Spring Harbor Perspectives in Biology, 6, a022616.
99. Watkins, E. B., Gao, H., Dennison, A. J., Chopin, N., Struth, B., Arnold, T., … Johannes, L. (2014). Carbohydrate conformation and lipid condensation in monolayers containing glycosphingolipid Gb3: Influence of acyl chain structure. Biophysical Journal, 107, 1146–1155.
100. Wilson, J. M., de Hoop, M., Zorzi, N., Toh, B. H., Dotti, C. G., & Parton, R. G. (2000). EEA1, a tethering protein of the early sorting endosome, shows a polarized distribution in hippocampal neurons, epithelial cells, and fibroblasts. Molecular Biology of the Cell, 11, 2657–2671.
101. Woodruff, B. A., Griffin, P. M., McCroskey, L. M., Smart, J. F., Wainwright, R. B., Bryant, R. G., … Hatheway, C. L. (1992). Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988. The Journal of Infectious Diseases, 166, 1281–1286.
102. Zachos, N. C., Alamelumangpuram, B., Lee, L. J., Wang, P., & Kovbasnjuk, O. (2014). Carbachol-mediated endocytosis of NHE3 involves a clathrin-independent mechanism requiring lipid rafts and Cdc42. Cellular Physiology and Biochemistry, 33, 869–881.